Sana Alajmovic, Co-founder and CEO of Sigrid Therapeutics AB
Ms. Sana Alajmovic, Co-Founder, CEO. Board member Sana Alajmovic is Co-Founder and Chief Executive Officer of Sigrid Therapeutics AB, with successful experience in commercializing research and discovery by establishing partnerships with global top tier biopharmaceutical actors. Sana Alajmovic was selected as Top 10 Under 40 of 2019 by Genetic Engineering News (GEN) as well as Biospace 10 Life Science Innovators Under 40 to Watch in 2019. She was named one of Sweden’s 101 Super Talents by the leading Swedish business magazine Veckans Affärer in 2012.
Related videos
/https%3A%2F%2Fwomenintech.se%2Fwp-content%2Fuploads%2F2024%2F05%2FSkarmbild-2024-05-21-124023.png)
Diversity, Equity & Inclusion (DEI) | Leadership & Career Paths
Frida Looman, Rebecca Hagnestad, Frida Nyvinger, Frida Looman, Rebecca Hagnestad, Frida Nyvinger | Bonnier News
How to Survive and Thrive about Being a Woman In Tech
/https%3A%2F%2Fwomenintech.se%2Fwp-content%2Fuploads%2F2024%2F05%2FSkarmbild-2024-10-02-221236.png)
Community & Social Impact | Sustainability & Innovation
Anna Ryott, Klara Leander, Tove Blomgren | EY
Sustainable business action
/https%3A%2F%2Fwomenintech.se%2Fwp-content%2Fuploads%2F2024%2F07%2FSkarmbild-2024-07-22-185032.png)
HR & Well-being | Trends & Foresight
Mickael Marceau, Mette Lorenzen, Usha Ganesan, Olga Hypponen, Charlotta Shelbourg | FDJ UNITED
How to build engagement and entertainment in a digital environment?